WO2003104489A3 - Variante du mchr1 associee a l'obesite humaine - Google Patents
Variante du mchr1 associee a l'obesite humaine Download PDFInfo
- Publication number
- WO2003104489A3 WO2003104489A3 PCT/EP2003/005917 EP0305917W WO03104489A3 WO 2003104489 A3 WO2003104489 A3 WO 2003104489A3 EP 0305917 W EP0305917 W EP 0305917W WO 03104489 A3 WO03104489 A3 WO 03104489A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- variant
- mchr1
- human obesity
- relates
- obesity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003236700A AU2003236700A1 (en) | 2002-06-05 | 2003-06-05 | Mchr1 variant associated with human obesity |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02012569 | 2002-06-05 | ||
| EP02012569.6 | 2002-06-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2003104489A2 WO2003104489A2 (fr) | 2003-12-18 |
| WO2003104489A3 true WO2003104489A3 (fr) | 2004-03-11 |
Family
ID=29724376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2003/005917 Ceased WO2003104489A2 (fr) | 2002-06-05 | 2003-06-05 | Variante du mchr1 associee a l'obesite humaine |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003236700A1 (fr) |
| WO (1) | WO2003104489A2 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006246116A1 (en) * | 2005-05-11 | 2006-11-16 | Aarhus Universitet | Method for diagnosis and treatment of a mental disease |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000075166A1 (fr) * | 1999-06-08 | 2000-12-14 | The Regents Of The University Of California | Recepteur de l'hormone concentratrice de la melanine |
| EP1288310A1 (fr) * | 2001-08-31 | 2003-03-05 | Aventis Pharma Deutschland GmbH | Utilisation de polymorphismes du nucléotide simple (SNP's) du récepteur (MCH-R) d'hormone concentrant la mélanine pour l'identification d'affections génétiques associées au maintien du poids du corps |
-
2003
- 2003-06-05 AU AU2003236700A patent/AU2003236700A1/en not_active Abandoned
- 2003-06-05 WO PCT/EP2003/005917 patent/WO2003104489A2/fr not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000075166A1 (fr) * | 1999-06-08 | 2000-12-14 | The Regents Of The University Of California | Recepteur de l'hormone concentratrice de la melanine |
| EP1288310A1 (fr) * | 2001-08-31 | 2003-03-05 | Aventis Pharma Deutschland GmbH | Utilisation de polymorphismes du nucléotide simple (SNP's) du récepteur (MCH-R) d'hormone concentrant la mélanine pour l'identification d'affections génétiques associées au maintien du poids du corps |
Non-Patent Citations (3)
| Title |
|---|
| BOUTIN JEAN A ET AL: "Melanin-concentrating hormone and its receptors: State of the art", CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, vol. 80, no. 5, May 2002 (2002-05-01), pages 388 - 395, XP001155641, ISSN: 0008-4212 * |
| DATABASE OMIM [online] XP002257865, accession no. OMIM Database accession no. OMIM 601751 * |
| DATABASE SNP [online] 6 December 2000 (2000-12-06), XP002257864, accession no. SNP Database accession no. rs133072 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003236700A1 (en) | 2003-12-22 |
| WO2003104489A2 (fr) | 2003-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA28149A1 (fr) | Compositions de vaccin comprenant une interleukine 18 et un systeme adjuvant de type saponine | |
| ATE364618T1 (de) | Antikörper gegen das muc18-antigen | |
| BRPI0408063A (pt) | métodos e composições envolvendo mda-7 | |
| MX338122B (es) | Epitopes terapeuticos y usos de los mismos. | |
| DE60226499D1 (de) | Verwendung von antikörpern gegen das muc18-antigen | |
| MA30252B1 (fr) | Vaccin therapeutique | |
| WO2003104270A3 (fr) | Genes de la duduline 2, produits d'expression, modele animal non humain : utilisations dans les maladies hematologiques humaines | |
| EP1528481A3 (fr) | Processeur exécutant des instructions SIMD | |
| MA28106A1 (fr) | Compositions immunogenes | |
| WO2003103550A3 (fr) | Systeme d'administration de medicament ou de composition augmentant le bien-etre | |
| GB0124145D0 (en) | Genes and proteins for prevention,prediction,prognosis and therapy of cardiovascular disease | |
| Ha | Suicide in Hong Kong 1971–1990: Age trend, sex ratio, and method of suicide | |
| EP2322206A3 (fr) | Nétrine 1 mutée, ses fragments et leur utilisation comme médicaments | |
| WO2003104489A3 (fr) | Variante du mchr1 associee a l'obesite humaine | |
| Ma et al. | Reliability and validity testing of a Chinese-translated version of the 39-item Parkinson’s Disease Questionnaire (PDQ-39) | |
| DK1694271T3 (da) | FSH-glykosyleringsmutant | |
| ES1052893U (es) | Instrumento de gimnasia de balanceo. | |
| BR0309808A (pt) | Combinação para o tratamento de distúrbios das vias aéreas | |
| Poglia Mileti et al. | Modern Sirens and their Populist Songs. A European Literature Review on Changes in Working Life and the Rise of Right-Wing Populism | |
| Bannikov | A new genus and species of putative centrolophid fish (Perciformes, Stromateoidei) from the Eocene of Bolca, northern Italy | |
| AU2003236714A8 (en) | Diagnosis of alzheimer's disease based on the habeta42:habeta40 ratio | |
| Burke et al. | Gaps in care of early onset colorectal cancer | |
| DE60222669D1 (de) | Asthma-assoziiertes gen | |
| ATE247500T1 (de) | Interventionsvorrichtung | |
| DE50214523D1 (de) | Nukleotidträger zur diagnose und therapie oraler erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |